Dr. Hirsch discusses the promising efficacy and safety of cevertinib for HER2-mutant non-small cell lung cancer, highlighting ...

Explore how evolving treatment strategies and biomarkers are transforming the management of HER2-positive breast cancer in clinical practice.

It seems there is no text provided for summarization. Please share the content you'd like summarized, and I'll be happy to help!

Jerry Shapiro, MD, discusses strategies for treating patients with scarring and nonscarring alopecia.

To set the stage for this milestone issue, Apathy reflects on the most significant health IT advancements of the past 15 ...

The American Academy of Pediatrics (AAP) released its 2026 child and adolescent immunization schedule, which continues to ...

D-VRd is the only quadruplet regimen approved for patients with newly diagnosed multiple myeloma, irrespective of transplant ...

ICE presence in health care settings is causing fear and healthcare avoidance, particularly among Hispanic/Latino and Somali ...

The CDC's revised schedule reduces routine vaccines from 17 to 11 diseases, with some vaccines now for high-risk groups or under shared decision-making. Experts criticize the lack of transparency and ...

The CDC announced that recommendations for vaccines for respiratory syncytial virus, hepatitis A, hepatitis B, dengue, and 2 types of bacterial meningitis were rolled back. 2 The vaccinations for flu, ...

Experts discuss groundbreaking therapies in dermatology at Maui Derm 2026, addressing complex skin diseases and enhancing patient care with innovative treatments.

CMS released its 2027 Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies, proposing a net average year-over-year payment ...